top of page
The Professional Network for Healthcare Experts
Kalohexis Files Confidentially for IPO to Advance Obesity and Cachexia Pipeline
The clinical-stage biotech plans to use a potential public listing to accelerate development of melanocortin-based therapies targeting obesity and cancer cachexia.
nuaxia
Jul 93 min read
Lilly’s Oral GLP-1 Foundayo Wins FDA Approval, Intensifying Obesity Drug Market Competition
New oral weight-loss treatment enters the market as competition with Novo Nordisk’s oral Wegovy accelerates.
nuaxia
Apr 21 min read
NMPA Approves Ecnoglutide for Chronic Weight Management in Adults with Overweight or Obesity
China authorises the first cAMP-biased GLP-1 receptor agonist for obesity, following robust Phase III SLIMMER trial results.
nuaxia
Mar 91 min read
bottom of page